Experimental virus and CAR t combo takes on Hard-to-Treat GI cancers
Disease control
Recruiting now
This early-stage trial is testing a new treatment called DISP-10 for people with advanced gastrointestinal cancers, including colorectal and stomach cancers. The treatment combines a virus (DV-10) with specially engineered immune cells (CAR T cells) to attack cancer. The study ai…
Phase: PHASE1 • Sponsor: Dispatch Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC